7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 
      
                              
      cash flows from operating activities:
                              
      net income
    -11,146,000 -16,593,000 -20,710,000 -34,531,000 -16,682,000 -17,181,000 -16,202,000 -29,273,000 -16,745,000 -11,942,000 -13,562,000 -18,608,000 -37,106,000 -5,933,000 -14,191,000 -14,678,000 -5,322,000 -6,948,000 -5,644,000 -4,247,000 -10,471,000 -17,759,000 -12,775,000 -9,040,000 -10,779,000 1,306,000 
      adjustments to reconcile net income to net cash from operating activities:
                              
      depreciation and amortization
    2,388,000 2,355,000 2,335,000 2,154,000 1,990,000 1,422,000 1,268,000 1,061,000 947,000 936,000 989,000 978,000 950,000 953,000 926,000 948,000 936,000 908,000 846,000 873,000 796,000 833,000 794,000 783,000 633,000 696,000 
      benefit from credit losses
    810,000 238,000 1,726,000  613,000 78,000 275,000                    
      benefit from inventory obsolescence
    764,000 804,000 650,000 1,012,000 275,000 -44,000 562,000 402,000 1,041,000 -387,000 90,000 217,000 -145,000 1,415,000 245,000 116,000 -116,000 93,000 -332,000 948,000 427,000 137,000 -71,000 61,000 -83,000  
      share-based compensation
    2,894,000 3,185,000 2,434,000 3,546,000 3,656,000 3,758,000 3,444,000 3,971,000 3,616,000 3,324,000 3,260,000 2,921,000 3,743,000 3,434,000 3,030,000 3,064,000 2,557,000 1,756,000 1,187,000 1,348,000 1,557,000 1,629,000 1,444,000 1,894,000 1,836,000  
      loss/(gain) from disposal of property and equipment
    64,000 -444,000 436,000                        
      unrealized foreign currency (gain)/ loss
    -531,000 -5,971,000 -3,510,000  -2,580,000 2,392,000 2,039,000 3,139,000 -2,051,000 -1,709,000   4,924,000 -2,889,000             
      amortization of right-to-use asset
    154,000 241,000 231,000 239,000 198,000 161,000 145,000 183,000 182,000 177,000 158,000 124,000 92,000 95,000 101,000 101,000 103,000 101,000         
      non-cash loss on contract termination
                             
      stock compensation in lieu of cash fees
    98,000 98,000 110,000 110,000 634,000 110,000 110,000                    
      interest capitalized for construction in progress
       -18,000 -537,000 -1,094,000 -1,125,000 -797,000                 
      non-cash interest expense and amortization of debt discount
    1,002,000 793,000 763,000 749,000 629,000 1,546,000 3,447,000 3,351,000    2,711,000              819,000 
      changes in operating assets and liabilities:
                              
      accounts receivable
    -1,310,000 -4,461,000 775,000 -5,146,000 -6,909,000 -9,615,000 -4,608,000 -4,655,000 -9,623,000 -5,356,000 -2,450,000 -865,000 -3,951,000 -5,067,000 100,000 -2,421,000 844,000 -5,218,000 514,000 -859,000 4,321,000 -171,000 -1,564,000 -832,000 -2,883,000 -2,207,000 
      inventory
    7,405,000 -5,390,000 -10,182,000 -11,337,000 -1,494,000 7,359,000 5,001,000 -13,880,000 -10,584,000 -8,494,000 -2,585,000 -7,351,000 -55,000 -909,000 -2,355,000 -4,212,000 -379,000 -698,000 6,508,000 1,513,000 -3,673,000 438,000 -1,282,000 -2,469,000 1,744,000 -2,339,000 
      prepaid expenses and other current assets
    1,078,000 -946,000 176,000 -261,000 -1,502,000 59,000 1,790,000 -898,000 41,000 -246,000 -1,298,000 -4,103,000 843,000 69,000 1,709,000 -4,443,000 -94,000 1,217,000 87,000 -1,624,000 3,327,000 -660,000 -2,715,000 592,000 -826,000 -2,394,000 
      other assets
    12,000 416,000 34,000 33,000 -2,000 -191,000 -323,000 110,000 -122,000 -137,000 187,000 -281,000 -20,000 -636,000 -114,000 163,000 15,000 26,000 -247,000 -34,000   53,000 -45,000 -11,000 786,000 
      accounts payable
    -16,323,000 10,031,000 1,354,000 11,047,000 6,625,000 -904,000 -10,097,000 4,999,000 5,157,000 -1,482,000 3,766,000 -769,000 -642,000 2,021,000 4,299,000 354,000 923,000 -617,000 2,357,000 -1,978,000 -1,655,000 366,000 1,270,000 3,032,000 -619,000 -1,973,000 
      accrued liabilities
    1,893,000 -3,392,000 4,038,000 1,898,000 2,501,000 -2,850,000 2,846,000 946,000 -2,395,000 2,236,000 123,000 1,078,000 -161,000 1,775,000 -2,102,000 4,615,000 2,371,000 -158,000 1,383,000 1,730,000 -45,000 40,000 1,255,000 1,567,000 1,142,000 980,000 
      operating lease liabilities
    -128,000 -240,000 -227,000 -203,000 -149,000 -152,000 -142,000 -174,000 -162,000 -175,000 -127,000 -70,000 -90,000 -91,000 -99,000 -97,000 -117,000 -95,000         
      other liabilities
    -374,000 -20,000 -1,158,000 1,696,000 -174,000 -119,000 -176,000 49,000 59,000 22,000 274,000 -171,000 195,000 -181,000 457,000 -94,000 1,000 -221,000 484,000 511,000 -24,000 19,000 -151,000 246,000 161,000 -464,000 
      net cash from operating activities
    -11,250,000 -18,753,000 -20,725,000 -20,749,000 -12,461,000 -14,154,000 -11,152,000 -31,511,000 -28,240,000 -20,614,000 -14,016,000 -21,980,000 -11,330,000 -4,840,000 -7,709,000 -12,455,000 -814,000 -6,554,000 3,434,000 -3,047,000 -6,095,000 -6,802,000 -10,896,000 -7,063,000 -7,998,000 -10,495,000 
      capex
    -1,848,000 -1,624,000 -753,000 -531,000 -1,473,000 -798,000 -3,312,000 -3,704,000 -3,117,000 -432,000 -966,000 -480,000 -607,000 -798,000 242,000 -963,000 -900,000 -804,000 -287,000 -846,000 -603,000 -687,000 -741,000 -4,197,000 -685,000 -561,000 
      free cash flows
    -13,098,000 -20,377,000 -21,478,000 -21,280,000 -13,934,000 -14,952,000 -14,464,000 -35,215,000 -31,357,000 -21,046,000 -14,982,000 -22,460,000 -11,937,000 -5,638,000 -7,467,000 -13,418,000 -1,714,000 -7,358,000 3,147,000 -3,893,000 -6,698,000 -7,489,000 -11,637,000 -11,260,000 -8,683,000 -11,056,000 
      cash flows from investing activities:
                              
      purchases of property and equipment
    -1,848,000 -1,624,000 -753,000 -531,000 -1,473,000 -798,000 -3,312,000 -3,704,000 -3,117,000 -432,000 -966,000 -480,000 -607,000 -798,000 242,000 -963,000 -900,000 -804,000 -287,000 -846,000 -603,000 -687,000 -741,000 -4,197,000 -685,000 -561,000 
      cash from business acquisitions, net of cash acquired
    -307,000                        
      cost incurred for intangible assets
    -112,000 -447,000 -276,000 -1,150,000 -1,132,000 -2,872,000 -1,879,000 -244,000 -77,000 -49,000 -282,000 -553,000 -266,000 -390,000 -1,000,000 -120,000 -33,000 -294,000 -837,000 -152,000 -233,000 -262,000 -14,000 -3,000 -7,000 
      capital expenditures on construction in progress
       -88,000 -160,000 -731,000 -1,435,000 -2,652,000 -5,855,000 -3,797,000 -9,180,000 -3,777,000 -12,416,000 -4,551,000             
      net cash from investing activities
    -1,960,000 -2,071,000 -1,336,000 -1,819,000 -2,765,000 -4,401,000 -6,626,000 -6,600,000 -9,049,000 -4,278,000 -10,428,000 -4,810,000 -13,814,000 -5,739,000 -3,615,000 -1,083,000 -933,000 -1,532,000 -1,124,000 -2,153,000 -1,333,000 -949,000 -741,000 -4,211,000 -1,455,000 -568,000 
      cash flows from financing activities:
                              
      issuance of common shares, net of underwriters’ discount and issuance costs
                              
      borrowings under oaktree credit agreement, net of debt discount and issuance costs
                              
      borrowings on short-term notes payable
    5,000,000                          
      proceeds from stock option exercises
    31,000 273,000 79,000 392,000 59,000 577,000 1,426,000 593,000 210,000 1,271,000 485,000 1,275,000 411,000 1,702,000 487,000 1,681,000 533,000 1,882,000 680,000 192,000 193,000 181,000 102,000 92,000 84,000 180,000 
      tax payments related to shares withheld upon vesting of restricted stock
    -77,000 -144,000 -282,000 -116,000 -87,000 -188,000 -119,000 -106,000 -282,000 -62,000 1,000    -268,000 -13,000 -34,000 -41,000 -89,000 -17,000 -14,000 -34,000 -44,000 -35,000 -56,000  
      net cash from financing activities
    29,454,000 5,129,000 -203,000 74,491,000 -28,000 389,000 51,043,000 487,000 84,492,000 1,183,000 24,977,000 1,265,000 72,318,000 1,695,000 207,000 1,637,000 422,000 1,786,000 538,000 90,000 116,000 63,926,000 22,466,000 -26,000 -16,000 65,283,000 
      effect of exchange rate changes on cash and cash equivalents
    -259,000 1,156,000 1,095,000 -1,273,000 351,000 -214,000 -320,000                    
      net decrease in cash and cash equivalents
                              
      cash and cash equivalents at beginning of period
    90,347,000  40,035,000                    
      cash and cash equivalents at end of period
    15,985,000 -14,539,000 69,178,000 50,650,000 -14,903,000 -18,380,000 72,980,000                    
      supplemental disclosures:
                              
      cash paid for interest
           1,418,000 1,422,000 1,360,000 1,179,000 1,171,000 1,306,000 1,707,000 1,745,000 1,745,000 1,727,000 1,710,000 1,749,000 1,749,000 1,730,000 1,734,000 1,468,000 1,322,000 1,402,000 1,345,000 
      cash paid for income taxes
           812,000 780,000 218,000 827,000 453,000 686,000 159,000 223,000 115,000 304,000 10,000 314,000 1,000 1,000 55,000 59,000 87,000 
      net increase in cash and cash equivalents
     -14,539,000 -21,169,000  -14,903,000 -18,380,000 32,945,000                    
      benefit from doubtful accounts
           287,000 143,000 282,000 -282,000 237,000 87,000 69,000 -277,000 355,000 116,000 6,000 -383,000 -213,000 372,000 599,000   112,000 90,000 
      change in reserve for pp&e impairment
           -341,000                 
      benefit from deferred income taxes
                              
      income from disposal of property and equipment
         35,000 6,000 -105,000 59,000 288,000 108,000 41,000 21,000 59,000 37,000 70,000 43,000 20,000 18,000 38,000 109,000 5,000 51,000 16,000 8,000  
      unrealized foreign currency (gain)/loss
                              
      loss on extinguishment of debt
                            
      gain from write-off of liability
                             
      change in fair value of derivative instruments
              -1,099,000 396,000 -191,000 -57,000 -259,000 -230,000 -1,190,000 -879,000 -1,492,000 1,929,000 -235,000 -2,640,000 32,000 -11,420,000 
      cash from asset acquisitions
                -434,000        
      issuance of common stock, net of underwriters’ discount and issuance costs
         49,736,000                   
      repayment of madryn debt agreement
                            
      repayments on finance leases
             -26,000 -9,000 -5,000 -5,000 -7,000 -12,000 -31,000 -77,000 -55,000         
      net (decrease)/increase in cash and cash equivalents
                              
      cash at beginning of period
           66,355,000 53,415,000 84,523,000 37,655,000 52,639,000 
      supplemental disclosures of non-cash investing and financing activities:
                              
      unpaid balance for property and equipment
           -340,000 95,000 1,514,000 1,097,000 -5,000 -14,000 51,000 -12,000 -34,000 -75,000 143,000 -42,000 -75,000 -68,000 395,000 -82,000 -83,000 705,000 -253,000 
      unpaid balance for intangible assets
                              
      equity consideration in an asset acquisition
                          337,000  
      equity consideration in a business acquisition
                              
      contingent consideration payable related to a business acquisition
                              
      consideration payable related to a business acquisition
                              
      cashless option exercises
                             
      cashless warrant exercises
                              
      cash payable to settle contract termination
                              
      liability to issue shares to settle contract termination
                              
      stock compensation in lieu of cash fees to non-employee directors
                              
      effect of exchange rate changes on cash
           -368,000 132,000 201,000 473,000 -385,000 -571,000 125,000 -91,000 -282,000 181,000 -273,000 244,000 159,000 98,000 -234,000   -35,000 -285,000 
      net increase in cash
           -37,992,000    -25,910,000              53,935,000 
      cash at end of period
           -37,992,000 47,335,000 42,847,000 1,006,000 -25,910,000 46,603,000 44,656,000 -11,208,000 -12,183,000 -1,144,000 77,950,000 3,092,000 -4,951,000 -7,214,000 93,596,000 10,689,000 -11,265,000 43,135,000 53,935,000 
      amortization of debt discount
             3,187,000    580,000 562,000 533,000 505,000 474,000 458,000 435,000 409,000 388,000 325,000 863,000 868,000  
      net decrease in cash
             -23,508,000    -8,759,000           -9,504,000  
      consideration payable related to asset acquisition
                 536,000 134,000 -4,000 9,000 407,000  39,000 -478,000 1,257,000 -43,000 20,000 1,257,000  
      benefit from fixed asset obsolescence
                              
      unrealized foreign currency loss
              -4,100,000    883,000 3,228,000 -2,941,000 3,030,000 -2,657,000 -604,000 -198,000 5,845,000     
      change in fair value of contingent consideration
                      -5,000 141,000 -440,000 -205,000 -137,000 -225,000 694,000 
      borrowings under oaktree debt agreement, net of debt discount and issuance costs
              24,500,000               
      proceeds from issuance of common shares, net of underwriters’ discount and issuance costs
                      63,855,000     
      net (decrease)/increase in cash
                  -11,208,000 -12,183,000 -1,144,000 -6,573,000 3,092,000 -4,951,000 -7,214,000 55,941,000 10,689,000    
      inventory acquired in an asset acquisition
                         153,000 1,104,000  
      issuance of common shares in settlement of contingent consideration
                              
      intangible assets acquired in an asset acquisition
                             
      cashless option exercise
                              
      borrowings under madryn credit agreement, net of issuance costs
                              
      cash used to repurchase warrants
                              
      proceeds from warrant exercises
                          58,000  
      assets acquired under finance leases
                              
      consideration payable related to asset acquisitions
                              
      repayments on capital leases
                       -85,000 -63,000 -76,000 -79,000 -83,000 -102,000 -73,000 
      assets acquired under capital leases
                          69,000 
      issuance of common shares in partial settlement of contingent consideration
                              
      cash from asset acquisition
                          -767,000  
      unrealized foreign currency (gain) loss
                          2,823,000 -825,000 892,000  
      repayments on related-party notes payable
                              
      proceeds from issuance of ordinary shares, net of issuance costs
                             2,000 
      proceeds from issuance of common shares, net of underwriters’ discount
                              
      deferred equity issuance costs, ipo
                              
      bad debt recovery
                              
      payments of deferred offering costs
                              
      unpaid deferred offering costs
                              
      •
                              
      write off of deferred offering costs
                              
      increase in restricted cash
                              
      repayments on short term notes payable
                              
      repayments under perceptive credit agreement
                              
      shares repurchased
                              
      extinguishment of warrants with related party
                              
      conversion of related party convertible notes payable into ordinary shares
                              
      stock-based compensation
                              
      subsidiary
                              
      establishment labs, s.a.
                              
      motiva usa, llc
                              
      jamm technologies, inc.
                              
      establishment labs produtos par saude ltda
                              
      european distribution center motiva bvba
                              
      motiva implants france sas
                              
      jen-vault ag
                              
      motiva nordica ab
                              
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.